Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
428.23
-0.20 (-0.05%)
Oct 16, 2026, 10:44 AM EDT - Market open
Elevance Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 92,870 | 77,906 | 85,556 | 110,797 | 122,511 | 112,508 | |
Market Cap Growth | 17.68% | -8.94% | -22.78% | -9.56% | 8.89% | 40.89% |
Enterprise Value | 113,682 | 101,424 | 104,942 | 125,705 | 138,384 | 130,821 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.05 | 13.76 | 14.31 | 18.51 | 20.79 | 18.27 |
PS Ratio | 0.46 | 0.39 | 0.48 | 0.65 | 0.78 | 0.81 |
PB Ratio | 2.07 | 1.77 | 2.07 | 2.81 | 3.37 | 3.11 |
P/FCF Ratio | 14.77 | 24.55 | 18.80 | 16.38 | 16.91 | 15.46 |
P/OCF Ratio | 12.45 | 18.16 | 14.73 | 13.75 | 14.59 | 13.45 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.57 | 0.51 | 0.59 | 0.73 | 0.88 | 0.94 |
EV/EBITDA Ratio | 13.66 | 11.22 | 9.97 | 11.48 | 14.51 | 13.29 |
EV/EBIT Ratio | 14.94 | 12.22 | 10.64 | 12.71 | 16.35 | 14.49 |
EV/FCF Ratio | 18.08 | 31.96 | 23.05 | 18.58 | 19.10 | 17.98 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.69 | 0.74 | 0.78 | 0.66 | 0.69 | 0.67 |
Debt / EBITDA Ratio | 3.67 | 3.57 | 3.01 | 2.34 | 2.58 | 2.37 |
Debt / FCF Ratio | 4.94 | 10.32 | 7.07 | 3.84 | 3.46 | 3.30 |
Net Debt / Equity Ratio | 0.46 | 0.53 | 0.58 | 0.49 | 0.49 | 0.53 |
Net Debt / EBITDA Ratio | 2.50 | 2.57 | 2.27 | 1.78 | 1.85 | 1.95 |
Net Debt / FCF Ratio | 3.31 | 7.33 | 5.25 | 2.87 | 2.44 | 2.63 |
Quick Ratio | 1.37 | 1.41 | 1.32 | 1.30 | 1.27 | 1.33 |
Current Ratio | 1.52 | 1.54 | 1.45 | 1.44 | 1.40 | 1.47 |
Asset Turnover | 1.62 | 1.67 | 1.57 | 1.62 | 1.56 | 1.51 |
Return on Equity (ROE) | 11.13% | 13.25% | 14.77% | 15.82% | 16.25% | 17.74% |
Return on Assets (ROA) | 3.83% | 4.35% | 5.46% | 5.84% | 5.28% | 6.13% |
Return on Invested Capital (ROIC) | 8.46% | 9.31% | 10.72% | 12.12% | 10.79% | 12.14% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.34% | 7.27% | 6.99% | 5.40% | 4.81% | 5.47% |
FCF Yield | 6.77% | 4.07% | 5.32% | 6.11% | 5.92% | 6.47% |
Dividend Yield | 1.61% | 1.94% | 1.73% | 1.24% | 0.99% | 0.97% |
Payout Ratio | 30.61% | 27.00% | 25.22% | 23.30% | 20.85% | 17.93% |
Buyback Yield / Dilution | 3.64% | 3.56% | 1.90% | 2.22% | 1.62% | 2.95% |
Total Shareholder Return | 5.25% | 5.50% | 3.63% | 3.47% | 2.61% | 3.92% |